CAS 413611-93-5

Formel: C18H12N4O3

InChl: InChI=1S/C18H12N4O3/c23-22(24)16-11-10-15(17-18(16)21-25-20-17)19-14-9-5-4-8-13(14)12-6-2-1-3-7-12/h1-11,19H

InChI Key: KMJPYSQOCBYMCF-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)C2=CC=CC=C2NC3=CC=C(C4=NON=C34)[N+](=O)[O-]

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine

CAS: 413611-93-5

Formel: C₁₈H₁₂N₄O₃

Reinheit: 97%

Farbe und Form: Solid

Molekulargewicht: 332.3129

Ref: IN-DA00C0XJ

10074-G5

CAS: 413611-93-5

10074-G5

Formel: C₁₈H₁₂N₄O₃

Reinheit: ≥95%

Molekulargewicht: 332.31

Ref: 54-BUP13086

10074-G5

CAS: 413611-93-5

Formel: C₁₈H₁₂N₄O₃

Molekulargewicht: 332.32

Ref: 4Z-K-031083

10074-G5

CAS: 413611-93-5

10074-G5 is an inhibitor of c-Myc-Max dimerization.

Formel: C₁₈H₁₂N₄O₃

Reinheit: 99.51% - 99.94%

Farbe und Form: Red Solid

Molekulargewicht: 332.31

Ref: TM-T3686

10074-G5

CAS: 413611-93-5

Ref: BE-RMCK020081

10074-G5

CAS: 413611-93-5

N-([1,1'-Biphenyl]-2-yl)-7-nitrobenzo[c][1,2,5]oxadiazol-4-amine

Formel: C₁₈H₁₂N₄O₃

Reinheit: 99%

Molekulargewicht: 332.31

Ref: IN-DG767022

c-Myc Inhibitor II

CAS: 413611-93-5

C-Myc Inhibitor II is a novel inhibitor of c-Myc transcriptional activity. It inhibits the proliferation of hematopoietic cells and has been shown to be effective in animal models of leukemia, lymphoma, and myeloma. C-Myc Inhibitor II also inhibits the growth of human tumor cells in culture. This drug inhibits the expression of genes related to cell cycle regulation, lipid metabolism, and DNA replication. C-Myc Inhibitor II binds to ATP levels, which may account for its ability to inhibit muscle cell proliferation.

Formel: C₁₈H₁₂N₄O₃

Reinheit: Min. 95%

Molekulargewicht: 332.31 g/mol

Ref: 3D-NRA61193

N-2-Biphenylyl-7-nitro-2,1,3-benzoxadiazol-4-aMine

CAS: 413611-93-5

Reinheit: 97%

Molekulargewicht: 332.3190002

Ref: 10-F866494